| 2023-12-05 |
| https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0002 |
| Variation |
| EMEA/H/N/PSR/J/0003 | trimetazidine | Trimetazidine | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0003-0 | Variation |
| EMEA/H/N/PSR/J/0005 | cyproterone;ethinylestradiol | Cyproterone / ethinylestradiol | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0005 | Variation |
| EMEA/H/N/PSR/J/0006 | cyproterone;ethinylestradiol | Cyproterone / ethinylestradiol | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0006 | Variation |
| EMEA/H/N/PSR/J/0008 | thiocolchicoside | Thiocolchicoside | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0008 | Variation |
| EMEA/H/N/PSR/J/0015 | domperidone | Domperidone | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0015 | Variation |
| EMEA/H/N/PSR/J/0023 | thiocolchicoside | Thiocolchicoside | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0023 | Variation |
| EMEA/H/N/PSR/J/0031 | hydroxyethyl starch | Hydroxyethyl starch | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0031 | Suspension |
| EMEA/H/N/PSR/S/0009 | poly (o-2-hydroxyethyl) starch | Poly (o-2-hydroxyethyl) starch | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0009 | Variation |
| EMEA/H/N/PSR/S/0016 | magnesium sulfate heptahydrate (BLI800);sodium sulfate anhydrous;potassium sulfate | Magnesium sulphate heptahydrate, sodium sulphate anhydrous, potassium sulphate | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0016 | Variation |
| EMEA/H/N/PSR/S/0017 | alanine;arginine;aspartic acid;cysteine;glucose;glutamic acid;glycine;histidine;isoleucine;leucine;lysine monohydrate;methionine;ornithine hydrochloride;phenylalanine;proline;serine;taurine;threonine;... | Numeta | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0017 | Variation |
| EMEA/H/N/PSR/S/0025 | teicoplanin | Teicoplanin | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0025 | Variation |
| EMEA/H/N/PSR/S/0028 | dexamfetamine | Dexamfetamine | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0028 | Variation |
| EMEA/H/N/PSR/S/0029 | dexamfetamine | Dexamfetamine | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0029 | Variation |
| EMEA/H/N/PSR/S/0033 | lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0033 | Variation |
| EMEA/H/N/PSR/S/0035 | dexketoprofen;tramadol | Dexketoprofen / tramadol | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0035 | Maintenance |
| PSUSA 00000048/201506 | aciclovir | Aciclovir | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/psusa-00000048-201506 | Maintenance |
| PSUSA 00010239202108 | magnesium sulfate;sodium sulfate;potassium sulfate | Magnesium sulfate, sodium sulfate, potassium sulfate | Human | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239202108 | Maintenance |
| PSUSA-00000230-201802 | aprotinin | Aprotinin | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/psusa-00000230-201802 | Maintenance |
| PSUSA-00000778-202212 | cisplatin | Cisplatin | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/psusa-00000778-202212 | Maintenance |
| PSUSA-00001276-202312 | dydrogesterone-estradiol | dydrogesterone-estradiol | Human | 2024-09-12 | https://www.ema.europa.eu/en/medicines/psusa/psusa-00001276-202312 | Variation |
| PSUSA-00001457-201708 | fluvastatin | Fluvastatin | 2023-12-05 | https://www.ema.europa.eu/en/medicines/psusa/psusa-00001457-201708 | Variation |
Procedure Number | Active Substance | Active Substances in Scope | Category | First Published Date | Last Updated Date | PSUSA URL | Regulatory Outcome | Related Medicines |
|---|